Dynavax Technologies (DVAX) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

There Is A Reason Dynavax Technologies Corporation's (NASDAQ:DVAX) Price Is Undemanding
Simply Wall StMar 1 08:59 ET
Dynavax Technologies' (NASDAQ:DVAX) Performance Is Even Better Than Its Earnings Suggest
Yahoo FinanceFeb 28 05:43 ET
Dynavax to Participate in Upcoming Investor Conferences
PR NewswireFeb 25 16:10 ET
Wall Street Analysts Think Dynavax Technologies (DVAX) Could Surge 81.92%: Read This Before Placing a Bet
Zacks Feb 24 09:00 ET
William Blair Maintains Dynavax Technologies(DVAX.US) With Buy Rating
Moomoo NewsFeb 21 20:31 ET · Ratings
Express News | Citizens Capital Markets Maintains Market Outperform on Dynavax Technologies, Raises Price Target to $33
BenzingaFeb 21 10:25 ET

Comments

Teddy123

Feb 19 18:12

Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy

$Dynavax Technologies (DVAX.US)$
Record Revenue vs Board Control: Inside Dynavax's $714M Battle with Deep Track Capital

Jaguar8

Jan 13 08:14

NEWS

$Dynavax Technologies (DVAX.US)$
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights
HEPLISAV-B revenue grew 26% YoY to $268 million in 2024
Q4 2024 revenue increased 39% YoY to $71 million
Strong cash position of $714 million
New $30 million DoD contract for plague vaccine development
Expected market expansion to $900 million by 2030 with 60% target market share
Negative
None.

Trytosaveabit

Jan 13 08:11

News

$Dynavax Technologies (DVAX.US)$ Dynavax Awarded $30M Contract With U.S. Department of Defense >DVAX
Dow Jones· 3 mins ago

Jaguar8

Nov 15, 2024 12:54

NEWS

$Dynavax Technologies (DVAX.US)$
Dynavax Technologies Down Over 7%, On Track for Largest Percent Decrease Since August 2022 -- Data Talk
Dow Jones· 2 mins ago2mins
Dynavax Technologies Corporation ( DVAX ) is currently at $12.42, down $0.97 or 7.21%
--Would be lowest close since Nov. 7, 2024, when it closed at $12.02
--On pace for largest percent decrease since Aug. 17, 2022, when it fell 10.39%
--Currently down three of the past four days
--Currently down two consecutive days; down 8.1% ov...

Jaguar8

Nov 7, 2024 15:07

NEWS

$Dynavax Technologies (DVAX.US)$
Dynavax Announces $200 Million Share Repurchase Program
Dynavax (DVAX) reported strong Q3 2024 financial results, with HEPLISAV-Bachieving record quarterly net product revenue of $79.3 million, up 27% year-over-year. The company's total revenues reached $80.6 million, a 16% increase from Q3 2023. HEPLISAV-B's U.S. market share grew to 44%, with particularly strong performance in retail pharmacy (55%) and IDN segments (56%). The company expects the hepatitis B...

DVAX Dynavax Technologies

Trade Overview

Capital Trend

News

Comments

Trending Stocks